USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate don Maganin Ciwon daji
Samfurasuna | Docetaxel Trihydrate |
Makamantu | (αR, βS) -β- [[(1,1-dimethylethoxy) carbonyl] amino] -a-hydroxy-benzenepropanoic acid, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS) -12b -(acetyloxy) -12- (benzoyloxy) -2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13 ,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4] benz [1,2-b] oxet-9-yl ester, hydrate (1: 3) |
CAS No. | 148408-66-6 |
Bayyanar | Fari zuwa kashe-fari crystalline foda |
Tsarin kwayoyin halitta | C43H53NO14.3 (H2O) |
Nauyin Kwayoyin Halitta | 861.94 |
Aikace-aikace | Matsayin Pharma ko manufar bincike |
Shiryawa | Kamar yadda kuka bukata |
Adana | Ajiye a cikin matsi, kwantena masu jure haske a wuri mai sanyi |
ABUBUWA | Ma'auni | SAKAMAKO |
Halaye | A: Farar zuwa kashe-fari crystalline foda | Ya dace |
B: Solubility: Insoluble a cikin ruwa, mai narkewa a cikin ethanol da acetone | Ya dace | |
MusammanRotation | ﹣38.5°~﹣41.5° | Ƙarfafa 40 ° |
Ganewa | 1.IR: Haka ne don duba samfurin | Ya dace |
2.UV: λmax232nm | Ya dace | |
| Ya dace | |
| Ya dace | |
Najasa | Jimlar ƙazanta: NMT 1.0% | 0.29% |
Najasa A: NMT 0.5% | 0.0551% | |
Najasa B: NMT 0.3% | 0.0470% | |
Najasa C: NMT 0.3% | 0.0535% | |
Duk wani ƙazanta guda ɗaya: NMT 0.1% | 0.0702% | |
Ruwa | 5.0% - 7.0% | 6.15% |
Ragowa akan kunnawa | NMT 0.1% w/w | 0.03% |
Karfe mai nauyi | NMT 20pm | Ya dace |
Assay | 97.5% ~ 102.0% | 99.7% |
Kammalawa | Ya hadu da EP7.5. |
Bayanin Kamfanin
√ Cikakken ƙwarewar gudanarwa a masana'anta da ƙwararrun masu bin fasaha; √ Quality ne ko da yaushe mu saman la'akari, M QC tsarin; √ 11 shekaru gogaggen fitar da tallace-tallace tawagar; √ R&D mai zaman kansa; √ Biyu da aka sanya hannu na dogon lokaci na GMP; √ wadataccen albarkatu na masana'antu marasa aiki da yawa don aikin da aka keɓance; √ Ƙwararren aiki mai inganci tare da madaidaiciyar hanya.Ku rubuta sakonku anan ku aiko mana